Navigation Links
Beta Blockers May Slow Spread of Breast Cancer
Date:3/26/2010

Small study found they boost survival, but results are preliminary

FRIDAY, March 26 (HealthDay News) -- Treatment with blood pressure-lowering drugs known as beta blockers appears to help reduce the spread of breast cancer in women, a team of British and German researchers report.

The drugs are believed to work by preventing stress hormones from stimulating cancer cells. "Beta- blocker drugs compete with stress hormones and bind to the same target receptors [on a cellular level], but unlike stress hormones, do not activate cancer cells," said Dr. Des Powe, a senior healthcare research scientist at Queen's Medical Centre, Nottingham University Hospital NHS Trust, in Nottingham, England.

Powe is due to present the findings Friday at the annual European Breast Cancer Conference in Barcelona, Spain.

Powe and his colleagues from the U.K. and Germany evaluated 466 cancer patients: 92 had received blood pressure-lowering medications and 43 of those 92, or nearly half, were on beta blockers at the time of their breast cancer diagnosis.

Those on beta blockers had a substantial reduction in the formation of distant cancers, or metastases, and of local recurrence. They had a 71 percent reduced risk of death from breast cancer during the study compared to those who were either taking other blood pressure drugs or weren't on any blood pressure medications. Those on beta blockers also had a 57 percent reduced risk of getting a secondary cancer.

"Our study was performed retrospectively, using patient notes [from women] that had received treatment in the late 1980s and 1990s," Powe said.

Other experts called the results interesting, but preliminary. "The concept of controlling tumor growth by preventing a stress or inflammatory response is not novel," said Dr. Cathie Chung, a medical oncologist and an assistant professor of oncology at the City of Hope National Medical Center in Duarte, Calif.

For instance, other research has found that women with breast cancer who regularly take aspirin, which is an anti-inflammatory, may have a decreased risk of recurrence.

"I think this study is interesting, but very far from being conclusive," said Chung. It's not known, she said, whether there is a true association or whether it may be due to chance or another factor.

"There is more work to be done before you can say whether this relationship is meaningful and will hold up," agreed Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.

As in other retrospective studies, he said, more research is needed to verify the potential link.

"There are many other factors that come into play that could explain what happened," Lichtenfeld said. "What if the women who take the beta blockers are more attuned to their health and they may be taking better care of themselves?"

Like Chung, he agreed the proposed association is not far-fetched, just that more study is needed. Previous research, Lichtenfeld said, has found a reduced rate of skin cancer among men who take another type of blood pressure-lowering drug.

Powe said he plans to do another study to validate the results.

More information

To learn more about inflammation and cancer, visit the U.S. National Cancer Institute.



SOURCES: Des Powe, Ph.D., senior healthcare research scientist, Queen's Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, U.K.; Len Lichtenfeld, M.D., Ph.D., deputy chief medical officer, American Cancer Society, Atlanta; Cathie Chung, M.D., Ph.D., medical oncologist and assistant professor, oncology, City of Hope National Medical Center, Duarte, Calif.; March 26, 2010, presentation, European Breast Cancer Conference, Barcelona


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Beta-blockers help reduce metastasis and improve survival in breast cancer patients
2. Widespread Public Defibrillators May Save Lives
3. Flexible Floor-Cleaning Routine Helps School Prevent Spread of Infection
4. H1N1 Flu Spreads Slower Than Seasonal Flu: Study
5. Proteins May Predict Spread of Colon Cancer
6. Freezing breast tumors helps stop cancer’s spread in mice, U-M study finds
7. Mayo Clinic researchers find oncogene is important in pancreatic cancer growth and spread
8. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
9. Fans Spread the Love on Target Facebook Page and Help Donate $1 Million to Five Charities
10. Family's Fight to Save Child Spreads Hope Around Globe
11. Researcher to track spread of disease, malware and power outages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , ... corporate headquarters to a new, more expansive office space in order to accommodate ... purchased a distressed office building in Wethersfield, Conn. located at 936 Silas Deane ...
(Date:3/28/2017)... Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... Marine Corp to raise money to for the Toys for Tots Literacy Campaign at ... federal budget in excess of $70 billion, the U.S. ranks at number 14 internationally ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Thank you ... Diego on February 8-10. , This event was exclusive to providers and offered ... , The meeting took place at the Manchester Grand Hyatt where attendees gathered for ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... clear braces. People who want straight teeth without the extensive time commitment and ... Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible aligners ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Therapix Biosciences ... company specializing in the development of cannabinoid-based drugs, today ... the United States of ... 40 ordinary shares of the Company, at a ... has granted the underwriters a 45-day over-allotment option ...
(Date:3/27/2017)... , March 27, 2017 LightIntegra Technology ... appointed William "Bill" Dubiel as President and Chief Executive ... elected to the Board of Directors of LightIntegra. ... Executive Chairman of LightIntegra. "This is ... President and Chief Executive Officer. We,ve selected a very ...
(Date:3/27/2017)... 27, 2017  A new survey from ... Medicare,s Competitive Bidding Program (CBP) significantly reduced beneficiary choice ... lack of choice forces beneficiaries to switch to unfamiliar ... consequences. AADE,s survey is the latest ... others pointing out the inherent problems with the CBP. ...
Breaking Medicine Technology: